Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 2500.00 | 1434.95 | 4265.00 | 4437.75 | 0.9611 | 0.9518 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4330.00 | 4437.75 | 0.9757 | 0.9701 | |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4256.00 | 4437.75 | 0.9590 | 0.9493 | |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 3373.00 | 4437.75 | 0.7601 | 0.6900 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 3366.00 | 4437.75 | 0.7585 | 0.6878 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 1237.00 | 4437.75 | 0.2787 | -0.0871 |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 2500.00 | 1434.95 | 2129.00 | 4437.75 | 0.4798 | 0.2741 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4407.00 | 4437.75 | 0.9931 | 0.9915 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4364.00 | 4437.75 | 0.9834 | 0.9795 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 2500.00 | 1434.95 | 4577.00 | 4437.75 | 1.0314 | 1.0383 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 1728.00 | 4437.75 | 0.3894 | 0.1209 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 2500.00 | 1434.95 | 4780.00 | 4437.75 | 1.0771 | 1.0933 |
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4353.00 | 4437.75 | 0.9809 | 0.9765 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 2500.00 | 1434.95 | 4463.00 | 4437.75 | 1.0057 | 1.0070 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 2500.00 | 1434.95 | 4536.00 | 4437.75 | 1.0221 | 1.0271 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 2500.00 | 1434.95 | 3349.00 | 4437.75 | 0.7547 | 0.6826 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 2500.00 | 1434.95 | 4604.00 | 4437.75 | 1.0375 | 1.0457 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4531.00 | 4437.75 | 1.0210 | 1.0257 |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 2500.00 | 1434.95 | 1298.00 | 4437.75 | 0.2925 | -0.0597 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4396.00 | 4437.75 | 0.9906 | 0.9884 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 2500.00 | 1434.95 | 4035.00 | 4437.75 | 0.9092 | 0.8865 |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 2500.00 | 1434.95 | 4155.00 | 4437.75 | 0.9363 | 0.9208 |
| BT-20 | Lapatinib | 1 | uM | 9 | 2500.00 | 1434.95 | 3743.00 | 4437.75 | 0.8435 | 0.8015 |
| BT-20 | 0 | uM | 9 | 2500.00 | 1434.95 | 4048.00 | 4437.75 | 0.9122 | 0.8903 | |
| BT-20 | 0 | uM | 9 | 5000.00 | 2808.68 | 7343.00 | 7795.00 | 0.9420 | 0.9205 |